Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke

The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.

Saved in:
Bibliographic Details
Main Authors EYDING DIRK, SOHNGEN WOLFGANG, SOHNGEN MARIOLA, SHAFEEK AL-RAWI YASIR A
Format Patent
LanguageEnglish
Published 22.06.2006
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.
Bibliography:Application Number: US20050264088